Skip to main content

Day: April 23, 2020

Fidelity D & D Bancorp, Inc. Announces Shareholder Approval Of the Acquisition of MNB Corporation

DUNMORE, Pa., April 23, 2020 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) (“Fidelity”), the parent bank holding company of The Fidelity Deposit and Discount Bank (“Fidelity Bank”), a Pennsylvania state-chartered, FDIC-insured community bank and trust company headquartered in Dunmore, PA, announced today that shareholders of Fidelity and MNB Corporation have approved the previously announced proposed acquisition of MNB Corporation by Fidelity. As previously disclosed, all requisite regulatory approvals have been received by the parties. The mergers of MNB Corporation with and into Fidelity and Merchants Bank of Bangor with and into Fidelity Bank are expected to be completed on May 1, 2020, subject to the satisfaction of customary closing conditions.About Fidelity D & D Bancorp, Inc.Fidelity D & D...

Continue reading

Northern Technologies International Corporation Suspends Quarterly Cash Dividend Pending Clarity on COVID-19

MINNEAPOLIS, April 23, 2020 (GLOBE NEWSWIRE) — Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today announced the temporary suspension of its quarterly cash dividend pending clarity on the COVID-19 crisis. G. Patrick Lynch, President and Chief Executive Officer of NTIC, stated: “The COVID-19 pandemic continues to have a material impact on the global economy. With many of our global customers currently running at a fraction of their regular capacity or locked down altogether, we anticipate sales for our third quarter to be down significantly.  Given this uncertainty, NTIC’s Board of Directors decided to temporarily suspend our quarterly cash dividend.  We will consider the reinstatement...

Continue reading

Menlo Therapeutics and Cutia Therapeutics Enter into Exclusive License Agreement for AMZEEQ™ and Approved Topical Minocycline Products in Greater China

BRIDGEWATER, N.J., April 23, 2020 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that its wholly-owned subsidiary, Foamix Pharmaceuticals Ltd. (“Foamix”), has entered into a licensing agreement with specialty pharmaceutical company Cutia Therapeutics (HK) Limited, an affiliate of Cutia Therapeutics (“Cutia”) for AMZEEQ™ (minocycline) topical foam, 4% as well as its other topical minocycline product candidates, once approved, on an exclusive basis in Greater China.Under the terms of the agreement, Cutia will have an exclusive license to obtain regulatory approval of and commercialize AMZEEQ™ and, if approved in the U.S., FMX103 and FCD105 in...

Continue reading

Beazley appoints underwriters to build product recall insurance offering for US businesses

New York, April 23, 2020 (GLOBE NEWSWIRE) — Specialist insurer Beazley is introducing a new product recall insurance policy for private enterprises in the United States, with a planned launch in the second quarter of 2020. The company has appointed a new underwriting team specifically to support the offering.The team is based in Farmington, Connecticut, and includes:Florian Beerli – product leadAngela Ives – underwriterJae Pak – underwriterAlex Marti – underwriterBeazley Product Recall will be available to US-domiciled companies and cover a range of risks from the small to large, with a primary focus on risks with up to $100 million in revenue.Florian Beerli, Beazley’s head of product recall, said: “The exposures related to product recalls are an ongoing and increasing occurrence regardless of size and industries. They pose a significant...

Continue reading

FactSet to Provide Fundamental and ESG Data to Government Pension Investment Fund

Content will fuel GPIF’s efforts to strengthen index selection and analysisTOKYO and NORWALK, Conn., April 23, 2020 (GLOBE NEWSWIRE) — FactSet (NYSE:FDS | NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading services, today announced that it will provide financial, non-financial, and benchmark data to the Government Pension Investment Fund (GPIF) of Japan. This content will support GPIF’s stated goal of improving the sophistication of its passive investment management through increased analysis of and engagement with index providers.FactSet will deliver over 20 content sets as part of GPIF’s introduction of its new Index Posting System. The Index Posting System will enhance GPIF’s overall fund management by efficiently collecting a range of information to facilitate more...

Continue reading

First Merchants Corporation Announces First Quarter 2020 Earnings per Share

MUNCIE, Ind., April 23, 2020 (GLOBE NEWSWIRE) — First Merchants Corporation (NASDAQ – FRME) has reported first quarter 2020 net income of $34.3 million compared to $38.8 million during the same period in 2019.  Earnings per share for the period totaled $.62 per share compared to the first quarter of 2019 result of $.78 per share.Total assets equaled $12.7 billion as of quarter-end and loans totaled $8.6 billion.  The Corporation’s loan portfolio increased by $1.3 billion, or 17.9 percent, during the past twelve months.  Total deposits equaled $9.9 billion as of quarter-end and increased by $1.8 billion, or 22.6 percent over the same period in 2019.  Of the increases, our acquisition of Monroe Bank & Trust (“MBT”), which closed on September 1, 2019, accounted for $733 million of loan growth and $1.1 billion of deposit...

Continue reading

Tabula Rasa HealthCare and Strategic Solutions Network Partner on a Free COVID-19 Medication Safety Webinar

MOORESTOWN, N.J., April 23, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare Corporation® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, and Strategic Solutions Network, a privately-held business-to-business conference company, will present a free webinar entitled Important Medication Safety Considerations for COVID-19 Treatment on Thursday, May 7, 2020 at 1 p.m. EDT. Participants may register here. The webinar will discuss the importance of understanding the risks associated with COVID-19 treatment risks, particularly with vulnerable individuals who have several chronic diseases and take multiple medications.“There is an unprecedented interest in medications that may have potential to treat COVID-19,” states TRHC Chairman and CEO Calvin H. Knowlton, PhD. “In this webinar, our Precision Pharmacotherapy...

Continue reading

Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC

SAN DIEGO, April 23, 2020 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it entered into a $15 million common stock purchase agreement and registration rights agreement with Lincoln Park Capital Fund, LLC (“LPC”), a Chicago-based institutional investor.Under the terms and conditions of the purchase agreement, Daré will have the right, from time to time and at its sole discretion, to sell up to $15 million of its stock to LPC over a 36-month period, subject to a registration statement covering the resale by LPC of shares issued and sold under the purchase agreement being filed and declared effective by the Securities and Exchange Commission (“SEC”) and satisfaction of the other conditions in the purchase agreement. Daré will control the timing and amount of any sales...

Continue reading

H2O Innovation: Genesys Launches New Water Treatment Product Range for the Mining Sector

QUEBEC CITY, April 23, 2020 (GLOBE NEWSWIRE) — (TSXV: HEO) – H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is pleased to announce a new product range from its independent subsidiary, Genesys, dedicated to the mining industry.The manufacturer of specialty chemicals for water treatment systems, Genesys, launched the Genmine range following three and a half years of exhaustive research and product development. The range includes antiscalants and cleaners designed to tackle issues specific to the treatment of minewater. There is also a software package to help plant operators work out which antiscalant to use and gauge the appropriate dosage level and frequency.The use of membranes to treat water in the mining industry has exploded in the last five years. Genesys has identified over 400 membrane plants being used around...

Continue reading

H2O Innovation : Genesys lance une nouvelle ligne de produits de traitement d’eau pour le secteur minier

QUÉBEC, 23 avr. 2020 (GLOBE NEWSWIRE) — (TSXV : HEO) – H2O Innovation inc. (« H2O Innovation » ou la « Société ») a le plaisir d’annoncer une nouvelle gamme de produits de sa filiale indépendante, Genesys, dédiée à l’industrie minière.Le fabricant de produits chimiques de spécialité pour les systèmes de traitement d’eau, Genesys, a lancé la gamme Genmine après trois ans et demi de recherche approfondie et de développement de produits. La ligne de produits comprend des antitartres et des nettoyants conçus pour s’attaquer aux problèmes spécifiques du traitement d’eaux de mine. Il existe également un logiciel pour aider les opérateurs d’usines à déterminer l’antitartre à utiliser et à évaluer le niveau ainsi que la fréquence de dosage appropriés.L’utilisation de membranes pour traiter l’eau...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.